ERECTILE FUNCTION AFTER CORPOROPLASTY IN PATIENTS WITH PEYRONIE’S DISEASE


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Purpose. To evaluate erectile function in patients with Peyronie’s disease (PD) who underwent corporoplasty. Materials and methods. A total of 374 patients who underwent corporoplasty by a single surgeon during 1996-2016 were analyzed. In all cases IIEF questionnaire was evaluated pre- and postoperatively. Intracavernous injection test and penile doppler ultrasonography were performed if required. Median follow-up was 9.5 years. Analysis of risk factors for erectile dysfunction (ED) before and after corporoplasty was performed. Results. Prevalence of risk factors for ED in our sample has greatly increased during follow-up. At the last follow-up visit 285 patients were sexually active. Evaluation of patient satisfaction with the quality of erections has shown that 139 patients were fully satisfied (48.8%), 84 patients were somewhat satisfied (29.5%) and 62 patients were not satisfied with their erectile function (21.7%). According to IIEF questionnaire, 105 patients (36.8%) had no ED (> 26 points); 74 patients (26%) had mild ED; 67 patients (23.5%) had mild-to-moderate ED; 21 patients (7.4%) had moderate ED; and 18 patients (6.3%) had severe ED. However, a causal relationship between ED and treatment of Peyronie's disease was found not in all cases. Seven patients had infrequent sexual intercourse (1-2 per month) and 50 patients had no sexual activity. Discussion. At long term after corporoplasty some patients experience ED, though causality between ED and PD treatment couldn’t be confirmed in all such cases. It should be noted that we have found an increase in prevalence of independent risk factors for ED during follow-up period. These patients could possibly benefit in terms of quality of life if they underwent penile prosthesis placement during primary surgical treatment for PD. However, some patients had no sexual activity due to causes unrelated to ED. Conclusion. Not all patients with PD are satisfied with their sexual functioning after corporoplasty. However, ED after surgical management of PD is not always a consequence of surgery itself.

Толық мәтін

Рұқсат жабық

Авторлар туралы

S. Gamidov

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia; IPO GBOU VPO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: safargamidov@yandex.ru
MD, professor at the Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Head of the Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia Moscow, Russia

V. Popkov

FGBOU VO Saratov State Medical University named after V.I. Razumovsky of the Ministry of Health of the Russian Federation

Email: kay1973@bk.ru
MD, Head of the Department of Urology Saratov, Russia

T. Shatylko

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Email: dialectic.law@gmail.com
Ph.D., urologist at the Department of Andrology and Urology Moscow, Russia

R. Ovchinnikov

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Email: r_ovchinnikov@oparina4.ru
Ph.D., Head of the Department of Andrology and Urology Moscow, Russia

A. Korolev

FGBOU VO Saratov State Medical University named after V.I. Razumovsky of the Ministry of Health of the Russian Federation

Email: kay1973@bk.ru
Ph.D., assistant at the Department of Urology Saratov, Russia

A. Popova

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Email: a_popova@oparina4.ru
Ph.D., senior researcher at the Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, associate professor at the Department of Obstetrics, Gynecology, Perinatology and Reproductology of IPO GBOU VPO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia Moscow, Russia

N. Gasanov

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Email: natiqhasan@gmail.com
urologist at the Department of Andrology and Urology Moscow, Russia

Әдебиет тізімі

  1. Shindel A.W., Bullock T.L., Brandes S. Urologist practice patterns in the management of Peyronie’s disease: A nationwide survey. The Journal of Sexual Medicine. 2008;5(4):954-964.
  2. Smith C.J., McMahon C., Shabsigh R. Peyronie’s disease: the epidemiology, aetiology and clinical evaluation of deformity. BJU International. 2005;95(6):729-732.
  3. Schwarzer U. et al. The prevalence of Peyronie’s disease: results of a large survey. BJU International. 2001;88(7):727-730.
  4. Usta M.F. et al. Stratification of penile vascular pathologies in patients with Peyronie’s disease and in men with erectile dysfunction according to age: a comparative study. The Journal of Urology. 2004;172(1):259-262.
  5. Шатылко Т.В. и др. Этиопатогенез и клиническая диагностика болезни Пейрони. Медицина в Кузбассе. 2017;1:14-18.
  6. Гамидов С.И. и др. Консервативное и хирургическое лечение болезни Пейрони. Фарматека. 2010;18-19:49-54.
  7. Котов С.В., Юсуфов А.Г., Семенов М.К. Трансплантат слизистой щеки-концепция «идеального графта» в хирургическом лечении болезни Пейрони. Урология. 2017;4:68-72.
  8. Weidner W. et al. Sexual dysfunction in Peyronie’s disease: an analysis of 222 patients without previous local plaque therapy. The Journal of Urology. 1997;157(1):325-328.
  9. Levine L.A., Latchamsetty K.C. Treatment of erectile dysfunction in patients with Peyronie’s disease using sildenafil citrate. International Journal of Impotence Research. 2002;14(6):478-482.
  10. Lopez J.A., Jarow J.P. Penile vascular evaluation of men with Peyronie’s disease. The Journal of Urology. 1993;149(1):53-55.
  11. Levine L.A., Coogan C.L. Penile vascular assessment using color duplex sonography in men with Peyronie’s disease. The Journal of Urology. 1996;155(4):1270-1273.
  12. Jarow J.P., Burnett A.L., Geringer A.M. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. The Journal of Urology. 1999;162(3):722-725.
  13. Althof S.E. et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999;53(4):793-799.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2019

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>